Effect of antioxidant supplementation on leucocyte expression of reactive oxygen species in athletes.
OBJECTIVE
Previous studies have shown that leucocytes, in particular granulocytes, have an enormous capacity for reactive oxygen species (ROS) production, and that this can be influenced by the physical activity of the individual. Theoretically, endurance-trained athletes could profit by increasing their intake of antioxidants, thus neutralizing increased ROS production. The aim of the present investigation was to study the effect of dietary antioxidant supplementation on leucocyte ROS expression and total plasma antioxidant status (TAS) in endurance-trained athletes over the course of 4 weeks.


METHODS
Eighteen athletes were recruited for the study. A randomized, double-blinded, placebo-controlled crossover study of 4 weeks of antioxidant supplementation (BiO-Antioxidant 2.1 (400 mg vitamin C and 180 mg vitamin E d(-1)) and BiO-Quinon Q10 (200 mg d(-1) was performed. Flow cytometry was applied to examine the leucocyte expression of ROS using the ROS-sensitive probes dihydroethidium and dihydrorhodamine 123. The Randox Total Antioxidant Status kit was used to measure the plasma TAS of the athletes.


RESULTS
After 4 weeks of antioxidant supplementation, we observed no significant differences in ROS levels in granulocytes and monocytes either basally or after in vitro stimulation with phorbol myristate acetate. Plasma TAS did not change significantly during the intervention period.


CONCLUSIONS
We observed no influence of 4 weeks of dietary antioxidant supplementation on oxidative stress status. Based on these findings, there is no rationale advising athletes to ingest antioxidant supplements in addition to their regular diet if that includes daily recommended doses of vitamins.
Center for Clinical Research Ullevaal University Hospital, University of Oslo, Norway. hdgn@c2i.net
Hilde Grindvik
HG
Nielsen
Ole Henning
OH
Skjønsberg
Torstein
T
Lyberg
D000328:Adult; D000975:Antioxidants / Q000378:metabolism / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007962:Leukocytes / Q000378:metabolism*; D008297:Male; D010101:Oxygen Consumption / Q000187:drug effects; D010807:Physical Endurance / Q000502:physiology*; D017382:Reactive Oxygen Species / Q000097:blood*; D013755:Tetradecanoylphorbol Acetate; D014810:Vitamin E / Q000097:blood
D000975:Antioxidants; D017382:Reactive Oxygen Species; D014810:Vitamin E; D013755:Tetradecanoylphorbol Acetate